Oncology Hematology Association — Pittsburgh, Pennsylvania

Oncology Hematology Association is a clinical research site located in Pittsburgh, Pennsylvania, United States 15232.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

Oncology Hematology Association has participated in 9 clinical trials with 8 currently active.

Therapeutic areas: Graft Versus Host Disease, Extensive Stage Lung Small Cell Carcinoma, Colon Adenocarcinoma.

Sponsors: Mesoblast, Inc., National Cancer Institute (NCI), NRG Oncology.

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Oncology Hematology Association?

Oncology Hematology Association has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Oncology Hematology Association conducted?

Oncology Hematology Association has 9 clinical trials on record, with 8 currently active. Their work covers Graft Versus Host Disease, Extensive Stage Lung Small Cell Carcinoma, Colon Adenocarcinoma.

Is Oncology Hematology Association accredited by Crixeo Health?

Yes — Oncology Hematology Association holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Oncology Hematology Association?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.